ZIM Laboratories (ZIMLAB.NS) Stock Price
ZIM Laboratories Price
Revenue has compounded at 5.5% per year over the past 13 years to 3.69 B INR. Earnings per share have declined at 3.7% per year over the last 13 years. ZIM Laboratories's net margin stands at 1.6%, down from 4.4% several years earlier. ZIM Laboratories currently offers a dividend yield of about 0.35%. The payout ratio is around 14% of earnings.
ZIM Laboratories stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
ZIM Laboratories business model & stock analysis
Frequently asked questions about ZIM Laboratories
Converted at the current exchange rate, the ZIM Laboratories share trades at 1.34 EUR (142.33 INR).
The revenue of ZIM Laboratories is 3.69 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of ZIM Laboratories is 58.38 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of ZIM Laboratories is currently 130.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ZIM Laboratories stock.
The price-to-sales ratio (P/S) of ZIM Laboratories is currently 2.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ZIM Laboratories stock.
The Eulerpool Quality Score for ZIM Laboratories is 1/10.
The ISIN of ZIM Laboratories is INE518E01015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of ZIM Laboratories is ZIMLAB.NS. The ticker symbol is used to trade ZIM Laboratories shares on the stock exchange.
ZIM Laboratories stock
ZIM Laboratories Peer Group
ZIM Laboratories FIGI
All fundamentals and in-depth analysis of ZIM Laboratories
Our stock analysis for ZIM Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ZIM Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.